{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:54:32Z","timestamp":1791640472262,"version":"4.3.4"},"reference-count":60,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T00:00:00Z","timestamp":1623801600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pediatr-neonatol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pediatrics &amp; Neonatology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.pedneo.2021.05.020","type":"journal-article","created":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T11:02:39Z","timestamp":1624100559000},"page":"581-590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Clinical and pathophysiologic relevance of autoantibodies in neonatal myasthenia gravis"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3391-3757","authenticated-orcid":false,"given":"Shigeo","family":"Iijima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pedneo.2021.05.020_bib1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrneurol.2016.44","article-title":"Myasthenia gravis-autoantibody characteristics and their implications for therapy","volume":"12","author":"Gilhus","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.pedneo.2021.05.020_bib2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jaut.2014.01.003","article-title":"Diagnostic and clinical classification of autoimmune myasthenia gravis","volume":"48\u201349","author":"Berrih-Aknin","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.pedneo.2021.05.020_bib3","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/ene.13788","article-title":"Maternal myasthenia gravis represents a risk for the child through autoantibody transfer, immunosuppressive therapy and genetic influence","volume":"25","author":"Gilhus","year":"2018","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.pedneo.2021.05.020_bib4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/088307389200700202","article-title":"Transient neonatal myasthenia gravis","volume":"7","author":"Papazian","year":"1992","journal-title":"J Child Neurol"},{"key":"10.1016\/j.pedneo.2021.05.020_bib5","series-title":"Volpe's neurology of the newborn","first-page":"909","article-title":"Neonatal transient myasthenia gravis","author":"Volpe","year":"2018"},{"key":"10.1016\/j.pedneo.2021.05.020_bib6","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1542\/peds.45.3.488","article-title":"Neonatal myasthenia gravis: report of two cases and review of the literature","volume":"45","author":"Namba","year":"1970","journal-title":"Pediatrics"},{"key":"10.1016\/j.pedneo.2021.05.020_bib7","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3389\/fimmu.2020.00212","article-title":"Autoantibody specificities in myasthenia gravis; implications for improved diagnostics and therapeutics","volume":"11","author":"Lazaridis","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.pedneo.2021.05.020_bib8","doi-asserted-by":"crossref","first-page":"25886","DOI":"10.1038\/srep25886","article-title":"Changes in inflammatory cytokine networks in myasthenia gravis","volume":"6","author":"Uzawa","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.pedneo.2021.05.020_bib9","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.pedneo.2021.05.020_bib10","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.autrev.2013.03.004","article-title":"Diagnosis and therapy of myasthenia gravis with antibodies muscle-specific kinase","volume":"12","author":"Evoli","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.pedneo.2021.05.020_bib11","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1172\/JCI66039","article-title":"Antibodies against low-density lipoprotein receptor-related protein 4 induce myasthenia gravis","volume":"123","author":"Shen","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pedneo.2021.05.020_bib12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jaut.2013.12.004","article-title":"A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis","volume":"52","author":"Zisimopoulou","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.pedneo.2021.05.020_bib13","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/mus.25438","article-title":"Agrin and low-density lipoprotein-related receptor protein 4 antibodies in amyotrophic lateral sclerosis patients","volume":"55","author":"Rivner","year":"2017","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.pedneo.2021.05.020_bib14","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1212\/WNL.38.1.138","article-title":"Neonatal myasthenia gravis: a new clinical and immunologic appraisal on 30 cases","volume":"38","author":"Morel","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.pedneo.2021.05.020_bib15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1212\/WNL.33.2.133","article-title":"Newborn infants to myasthenic mothers: a clinical study and an investigation of acetylcholine receptor antibodies in 17 children","volume":"33","author":"Lefvert","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.pedneo.2021.05.020_bib16","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1017\/S0317167100043730","article-title":"Neonatal myasthenia gravis in the infant of an asymptomatic thymectomized mother","volume":"9","author":"Olanow","year":"1982","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.pedneo.2021.05.020_bib17","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ana.410060119","article-title":"Neonatal myasthenia gravis in the infant of a myasthenic mother in remission","volume":"6","author":"Elias","year":"1979","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pedneo.2021.05.020_bib18","first-page":"938","article-title":"Seronegative neonatal myasthenia gravis in one of the twins","volume":"41","author":"Sisman","year":"2004","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.pedneo.2021.05.020_bib19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0896-8411(91)90017-7","article-title":"Anti-acetylcholine receptor antibodies in neonatal myasthenia gravis: heterogeneity and pathogenic significance","volume":"4","author":"Eymard","year":"1991","journal-title":"J Autoimmun"},{"key":"10.1016\/j.pedneo.2021.05.020_bib20","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1172\/JCI117369","article-title":"Association of neonatal myasthenia gravis with antibodies against the fetal acetylcholine receptor","volume":"94","author":"Vernet-der-Garabedian","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pedneo.2021.05.020_bib21","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/1096-9926(200011)62:5<332::AID-TERA7>3.0.CO;2-E","article-title":"Teratogen update: maternal myasthenia gravis as a cause of congenital arthrogryposis","volume":"62","author":"Polizzi","year":"2000","journal-title":"Teratology"},{"key":"10.1016\/j.pedneo.2021.05.020_bib22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1212\/WNL.48.1.50","article-title":"The fetal\/adult acetylcholine receptor antibody ratio in mothers with myasthenia gravis as a marker for transfer of the disease to the newborn","volume":"48","author":"Gardnerova","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.pedneo.2021.05.020_bib23","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1073\/pnas.77.6.3635","article-title":"Inhibitory effect of \u03b1-fetoprotein on the binding of myasthenia gravis antibody to acetylcholine receptor","volume":"77","author":"Brenner","year":"1980","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pedneo.2021.05.020_bib24","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.nmd.2012.01.002","article-title":"Fetal acetylcholine receptor inactivation syndrome and maternal myasthenia gravis: a case report","volume":"22","author":"D'Amico","year":"2012","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.pedneo.2021.05.020_bib25","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/mus.22006","article-title":"Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts","volume":"44","author":"Guptill","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.pedneo.2021.05.020_bib26","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.2169\/internalmedicine.8636-16","article-title":"Emergency caesarean section saved both an anti-MuSK antibody-positive myasthenia gravis mother with pregnancy-induced hypertension and her premature baby","volume":"56","author":"Takahashi","year":"2017","journal-title":"Intern Med"},{"key":"10.1016\/j.pedneo.2021.05.020_bib27","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000506189","article-title":"Myasthenia gravis with anti-muscle-specific tyrosine kinase antibody during pregnancy and risk of neonatal myasthenia gravis: a case report and review of the literature","volume":"12","author":"Inoue","year":"2020","journal-title":"Case Rep Neurol"},{"key":"10.1016\/j.pedneo.2021.05.020_bib28","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1212\/01.wnl.0000307751.20968.f1","article-title":"A transient neonatal myasthenic syndrome with anti-musk antibodies","volume":"70","author":"Niks","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.pedneo.2021.05.020_bib29","doi-asserted-by":"crossref","first-page":"188","DOI":"10.5692\/clinicalneurol.51.188","article-title":"A pregnant patient with anti-MuSK antibody positive myasthenia gravis and her infant with transient neonatal myasthenia gravis.","volume":"51","author":"Kanzaki","year":"2011","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.pedneo.2021.05.020_bib30","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1474-7766.2005.00317.x","article-title":"Myasthenia gravis with MuSK antibodies","volume":"5","author":"Farrugia","year":"2005","journal-title":"Practical Neurology"},{"key":"10.1016\/j.pedneo.2021.05.020_bib31","first-page":"127","article-title":"Case report of a neonate born to the mother with anti-MuSK antibodies.","volume":"43","author":"Hibi","year":"2007","journal-title":"Jpn Soc Perin Neon Med"},{"key":"10.1016\/j.pedneo.2021.05.020_bib32","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.nmd.2008.03.006","article-title":"Severe neonatal myasthenia due to maternal anti-MuSK antibodies","volume":"18","author":"B\u00e9hin","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.pedneo.2021.05.020_bib33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/CND.0b013e3181a78280","article-title":"Transient neonatal myasthenia gravis in a baby born to a mother with new-onset anti-MuSK-mediated myasthenia gravis","volume":"11","author":"O'Carroll","year":"2009","journal-title":"J Clin Neuromuscul Dis"},{"key":"10.1016\/j.pedneo.2021.05.020_bib34","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/CND.0b013e3181f8a9aa","article-title":"Transmission of maternal muscle-specific tyrosine kinase (MuSK) to offspring: report of two cases","volume":"12","author":"Murray","year":"2010","journal-title":"J Clin Neuromuscul Dis"},{"key":"10.1016\/j.pedneo.2021.05.020_bib35","first-page":"80","article-title":"[A case of anti-MuSK antibody-positive myasthenia gravis complicated with severe preeclampsia.]","volume":"35","author":"Ohashi","year":"2013","journal-title":"Okinawa Sanka Fujinka Gakkai zasshi"},{"key":"10.1016\/j.pedneo.2021.05.020_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-207708","article-title":"Anti-MuSK-positive myasthenia gravis diagnosed during pregnancy: new challenges for an old disease?","volume":"2015","author":"Neves","year":"2015","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.pedneo.2021.05.020_bib37","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.nmd.2017.03.012","article-title":"Transient neonatal myasthenia gravis due to a mother with ocular onset of anti-muscle specific kinase myasthenia gravis","volume":"27","author":"Lee","year":"2017","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.pedneo.2021.05.020_bib38","first-page":"275","article-title":"Pregnancy in women with anti-muscle-specific tyrosine kinase antibody-positive myasthenia gravis: a case report.","volume":"68","author":"Horiuchi","year":"2019","journal-title":"Modern Trends in Obstetrics & Gynecology"},{"key":"10.1016\/j.pedneo.2021.05.020_bib39","first-page":"71","article-title":"Pregnancy with anti-MuSK-positive myasthenia gravis that was diagnosed during pregnancy: a case report","volume":"64","author":"Masuyama","year":"2019","journal-title":"J Reprod Med"},{"key":"10.1016\/j.pedneo.2021.05.020_bib40","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.nmd.2017.11.014","article-title":"MuSK myasthenia gravis and pregnancy","volume":"28","author":"Santos","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.pedneo.2021.05.020_bib41","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/WCO.0b013e32833c32af","article-title":"Acquired myasthenia gravis in childhood","volume":"23","author":"Evoli","year":"2010","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.pedneo.2021.05.020_bib42","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.clim.2014.02.012","article-title":"Preferential production of IgG1, IL-4 and IL-10 in MuSK-immunized mice","volume":"151","author":"Ulusoy","year":"2014","journal-title":"Clin Immunol"},{"key":"10.1016\/j.pedneo.2021.05.020_bib43","article-title":"Differential cytokine changes in patients with myasthenia gravis with antibodies against AChR and MuSK","volume":"10","author":"Yimaz","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pedneo.2021.05.020_bib44","doi-asserted-by":"crossref","first-page":"398","DOI":"10.4049\/immunohorizons.1800076","article-title":"IL-10 indirectly downregulates IL-4-induced IgE production by human B cells","volume":"2","author":"Lin","year":"2018","journal-title":"Immunohorizons"},{"key":"10.1016\/j.pedneo.2021.05.020_bib45","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3389\/fimmu.2014.00253","article-title":"Regulation of the anti-inflammatory cytokines interleukin-4 and interleukin-10 during pregnancy","volume":"5","author":"Chatterjee","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.pedneo.2021.05.020_bib46","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0887-8994(97)00174-4","article-title":"High-dose intravenous immunoglobin in transient neonatal myasthenia gravis","volume":"18","author":"Bassan","year":"1998","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.pedneo.2021.05.020_bib47","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0022-3476(99)70422-1","article-title":"Failure of intravenously administered immunoglobulin in the treatment of neonatal myasthenia gravis","volume":"134","author":"Tagher","year":"1999","journal-title":"J Pediatr"},{"key":"10.1016\/j.pedneo.2021.05.020_bib48","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1080\/08916934.2016.1214823","article-title":"Effect of therapeutic plasma exchange on immunoglobulins in myasthenia gravis","volume":"49","author":"Guptill","year":"2016","journal-title":"Autoimmunity"},{"key":"10.1016\/j.pedneo.2021.05.020_bib49","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1053\/j.ajkd.2008.02.360","article-title":"Therapeutic plasma exchange: core curriculum 2008.","volume":"52","author":"Kaplan","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.pedneo.2021.05.020_bib50","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1212\/WNL.31.7.911","article-title":"Exchange transfusion in neonatal myasthenia gravis","volume":"31","author":"Donat","year":"1981","journal-title":"Neurology"},{"key":"10.1016\/j.pedneo.2021.05.020_bib51","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.3389\/fimmu.2019.03052","article-title":"Antagonism of the neonatal Fc receptor as an emerging treatment for myasthenia gravis","volume":"10","author":"Gable","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.pedneo.2021.05.020_bib52","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.expneurol.2019.03.001","article-title":"Efgartigimod improves muscle weakness in a mouse model for muscle-specific kinase myasthenia gravis","volume":"317","author":"Huijbers","year":"2019","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pedneo.2021.05.020_bib53","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4103\/ijp.IJP_452_17","article-title":"Management of myasthenia gravis during pregnancy","volume":"50","author":"Bansal","year":"2018","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.pedneo.2021.05.020_bib54","author":"American Society of Health-System Pharmacists"},{"key":"10.1016\/j.pedneo.2021.05.020_bib55","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1136\/jnnp-2013-305572","article-title":"Myasthenia in pregnancy: best practice guidelines from a U.K. multispecialty working group","volume":"85","author":"Norwood","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.pedneo.2021.05.020_bib56","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ejcts.2005.11.022","article-title":"Effect of pregnancy and birth on the course of myasthenia gravis before or after transsternal radical thymectomy","volume":"29","author":"Roth","year":"2006","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.pedneo.2021.05.020_bib57","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1055\/s-0036-1579624","article-title":"Seronegative maternal ocular myasthenia gravis and delayed transient neonatal myasthenia gravis","volume":"6","author":"Townsel","year":"2016","journal-title":"AJP Rep"},{"key":"10.1016\/j.pedneo.2021.05.020_bib58","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1212\/01.wnl.0000254620.45529.97","article-title":"Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis","volume":"68","author":"Deymeer","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.pedneo.2021.05.020_bib59","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0165-5728(86)90028-7","article-title":"Neonatal myasthenia gravis: clinical and immunological study of seven mothers and their newborn infants","volume":"12","author":"Bartoccioni","year":"1986","journal-title":"J Neuroinmunol"},{"key":"10.1016\/j.pedneo.2021.05.020_bib60","first-page":"711","article-title":"Studies in myasthenia gravis: neonatal and juvenile types","volume":"23","author":"Osserman","year":"1956","journal-title":"J Mt Sinai Hosp N Y"}],"container-title":["Pediatrics &amp; Neonatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875957221001030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875957221001030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:55:18Z","timestamp":1761749718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875957221001030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":60,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1875957221001030"],"URL":"https:\/\/doi.org\/10.1016\/j.pedneo.2021.05.020","relation":{},"ISSN":["1875-9572"],"issn-type":[{"value":"1875-9572","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and pathophysiologic relevance of autoantibodies in neonatal myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Pediatrics & Neonatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pedneo.2021.05.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Taiwan Pediatric Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}